Chandra Bhagat Pharma Limited (BOM:542934)

Chandra Bhagat Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	473.44	867.16	2,214	1,197	940.76	706.95
Other Revenue	20.51	20.51	11.3	-	-	0.02
Revenue	493.95	887.67	2,225	1,197	940.76	706.97
Revenue Growth (YoY)	-70.63%	-60.10%	85.93%	27.21%	33.07%	-24.78%
Cost of Revenue	357.35	734.81	2,083	1,068	814.41	598.3
Gross Profit	136.59	152.86	142.31	129.04	126.34	108.67
Selling, General & Admin	28.47	29.36	29.68	18.25	21.31	25.1
Other Operating Expenses	75.04	91.74	74.53	71.48	52.63	38.16
Operating Expenses	115	130.62	110.63	92.39	75.18	64.46
Operating Income	21.59	22.24	31.69	36.66	51.17	44.21
Interest Expense	-17.58	-17.96	-12.87	-21.75	-29.84	-35.55
Interest & Investment Income	0.16	0.16	0.07	0.03	1.54	0.66
Currency Exchange Gain (Loss)	6.76	6.76	7.7	-0.61	-9.29	-3.59
Other Non Operating Income (Expenses)	-1.52	-1.52	-1	-0.23	-2.53	-2.03
EBT Excluding Unusual Items	9.42	9.68	25.58	14.09	11.05	3.71
Gain (Loss) on Sale of Investments	-	-	-	0.01	-	-
Gain (Loss) on Sale of Assets	2.31	2.31	-	-	-	-
Pretax Income	11.73	11.99	25.58	14.11	11.05	3.71
Income Tax Expense	5.51	3.41	10.28	5.05	3.08	1.81
Net Income	6.22	8.58	15.3	9.05	7.97	1.9
Net Income to Common	6.22	8.58	15.3	9.05	7.97	1.9
Net Income Growth	-60.64%	-43.95%	69.02%	13.64%	319.54%	-39.67%
Shares Outstanding (Basic)	8	8	8	8	8	8
Shares Outstanding (Diluted)	8	8	8	8	8	8
Shares Change (YoY)	-0.06%	-	-	-	-	31.87%
EPS (Basic)	0.83	1.14	2.03	1.20	1.06	0.25
EPS (Diluted)	0.83	1.14	2.03	1.20	1.06	0.25
EPS Growth	-60.62%	-43.95%	69.02%	13.64%	322.37%	-54.55%
Free Cash Flow	14.35	-67.84	38.94	48.96	122.99	83.08
Free Cash Flow Per Share	1.91	-8.99	5.16	6.49	16.30	11.01
Gross Margin	27.65%	17.22%	6.40%	10.78%	13.43%	15.37%
Operating Margin	4.37%	2.50%	1.42%	3.06%	5.44%	6.25%
Profit Margin	1.26%	0.97%	0.69%	0.76%	0.85%	0.27%
Free Cash Flow Margin	2.90%	-7.64%	1.75%	4.09%	13.07%	11.75%
EBITDA	32.4	31.06	36.56	37.77	51.55	44.55
EBITDA Margin	6.56%	3.50%	1.64%	3.16%	5.48%	6.30%
D&A For EBITDA	10.81	8.82	4.87	1.11	0.38	0.34
EBIT	21.59	22.24	31.69	36.66	51.17	44.21
EBIT Margin	4.37%	2.50%	1.42%	3.06%	5.44%	6.25%
Effective Tax Rate	46.95%	28.45%	40.18%	35.82%	27.89%	48.74%
Revenue as Reported	500.99	922.05	2,327	1,200	956.96	711.71
Advertising Expenses	-	0.02	1.03	-	0.38	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.